Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in multiple myeloma patients undergoing autologous stem cell transplantation
IRCT20230315057722N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pentoxifylline in multiple myeloma (MM) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: T regulatory cells, T CD8+ IL-10 and 2 more. Started May 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on IRCT20230315057722N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230315057722N1.